DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia
- Resource Type
- Article
- Source
- In
Molecular Genetics and Metabolism November 2023 140(3) - Subject
- Language
- ISSN
- 1096-7192